DK1056454T3 - Anvendelse af makrolidforbindelser til behandling af glaukom - Google Patents

Anvendelse af makrolidforbindelser til behandling af glaukom

Info

Publication number
DK1056454T3
DK1056454T3 DK99905206T DK99905206T DK1056454T3 DK 1056454 T3 DK1056454 T3 DK 1056454T3 DK 99905206 T DK99905206 T DK 99905206T DK 99905206 T DK99905206 T DK 99905206T DK 1056454 T3 DK1056454 T3 DK 1056454T3
Authority
DK
Denmark
Prior art keywords
treatment
glaucoma
macrolide compounds
compounds
macrolide
Prior art date
Application number
DK99905206T
Other languages
English (en)
Inventor
Shozo Sakuma
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPP1955A external-priority patent/AUPP195598A0/en
Priority claimed from AUPP2992A external-priority patent/AUPP299298A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of DK1056454T3 publication Critical patent/DK1056454T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99905206T 1998-02-23 1999-02-17 Anvendelse af makrolidforbindelser til behandling af glaukom DK1056454T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP1955A AUPP195598A0 (en) 1998-02-23 1998-02-23 New use
AUPP2992A AUPP299298A0 (en) 1998-04-16 1998-04-16 New use
PCT/JP1999/000681 WO1999042104A1 (en) 1998-02-23 1999-02-17 Use of macrolide compounds for treating glaucoma

Publications (1)

Publication Number Publication Date
DK1056454T3 true DK1056454T3 (da) 2003-08-18

Family

ID=25645716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99905206T DK1056454T3 (da) 1998-02-23 1999-02-17 Anvendelse af makrolidforbindelser til behandling af glaukom

Country Status (9)

Country Link
US (1) US6384073B1 (da)
EP (1) EP1056454B1 (da)
JP (1) JP2002503692A (da)
AT (1) ATE238792T1 (da)
DE (1) DE69907418T2 (da)
DK (1) DK1056454T3 (da)
ES (1) ES2192832T3 (da)
PT (1) PT1056454E (da)
WO (1) WO1999042104A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7265150B1 (en) * 1998-08-14 2007-09-04 Gpi Nil Holdings Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
US7338976B1 (en) * 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6376517B1 (en) * 1998-08-14 2002-04-23 Gpi Nil Holdings, Inc. Pipecolic acid derivatives for vision and memory disorders
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
PT1227859E (pt) * 1999-11-12 2006-12-29 Alcon Inc Ligandos da neurofilina para o tratamento de patologias oculares
GB0012383D0 (en) * 2000-05-22 2000-07-12 Novartis Ag Organic compounds
AU2003209297A1 (en) * 2002-01-18 2003-09-02 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7083802B2 (en) 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
AU2006270041B2 (en) 2005-07-18 2011-08-18 Minu, Llc Enhanced ocular neuroprotection/neurostimulation
US7592330B2 (en) * 2005-08-08 2009-09-22 Massachusetts Eye And Ear Infirmary Methods and compositions for preserving the viability of photoreceptor cells
EP1956906A4 (en) 2005-11-09 2009-12-30 Combinatorx Inc METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES
EP2077819A4 (en) 2006-09-28 2011-05-25 Follica Inc METHODS, MATERIALS, AND COMPOSITIONS FOR GENERATING NEW CELLULAR FOLLICLES AND PUSHING HAIR
JP2010514790A (ja) * 2006-12-28 2010-05-06 リメリック バイオファーマ， インコーポレイテッド 治療処置のための方法および組成物
EP2124898B1 (en) 2007-01-10 2013-08-14 Board of Regents, The University of Texas System Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery
CA2693338A1 (en) * 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Phosphorylated pyrone analogs and methods
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
WO2012118863A1 (en) * 2011-02-28 2012-09-07 The Schepens Eye Research Institute, Inc. Therapies that target autoimmunity for treating glaucoma and optic neuropathy
CA2935167C (en) 2014-01-16 2022-02-22 Musc Foundation For Research Development Targeted nanocarriers for the administration of immunosuppressive agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
ATE198708T1 (de) * 1991-04-26 2001-02-15 Fujisawa Pharmaceutical Co Verwendung von makrolid-verbindungen gegen augenerkrankungen
IL102414A (en) * 1991-07-25 1996-08-04 Univ Louisville Res Found Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
US5922773A (en) * 1992-12-04 1999-07-13 The Children's Medical Center Corp. Glaucoma treatment
US5912224A (en) * 1996-02-22 1999-06-15 The General Hospital Corporation Methods and compositions for enhancing cellular response to TGF-β ligands
US5994388A (en) * 1997-03-18 1999-11-30 The Children's Medical Center Corporation Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis

Also Published As

Publication number Publication date
JP2002503692A (ja) 2002-02-05
DE69907418T2 (de) 2003-11-13
ES2192832T3 (es) 2003-10-16
EP1056454B1 (en) 2003-05-02
EP1056454A1 (en) 2000-12-06
WO1999042104A1 (en) 1999-08-26
ATE238792T1 (de) 2003-05-15
PT1056454E (pt) 2003-08-29
US6384073B1 (en) 2002-05-07
DE69907418D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
PE14199A1 (es) Agonistas de 5-ht1f
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
DK0915898T3 (da) Krystalform I af clarithromycin
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DK1384478T3 (da) Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
ATE292971T1 (de) (s,s)-reboxetin zur behandlung von peripheren neuropathien
NO20004872L (no) FremgangsmÕte for Õ stabilisere farmasøytiske sammensetninger ved spesiell anvendelse av en antioksidant
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
ES2243579T3 (es) Derivados de pirazolopirideno.
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
ATE180781T1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
WO2002024695A3 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
DK1059921T3 (da) Anvendelse af macrolidforbindelser til behandling af ARDS
ID25478A (id) Agonis 5-ht1f
EP1121932A4 (en) DRUGS FOR EYE DISEASES
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati